Solas BioVentures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Aurenaraurenar.comJul 2026
Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients.
HardwareHealthtechMedical Devices
Eric Leuthardt(Chief Executive Officer & Founder)inJenna Gorlewicz(Chief Technology Officer & Founder)inAnna Huguenard(Chief Medical Officer & Founder)inJesse Wheeler(Chief Operations Officer)inRyan Kight(Chief Financial Officer)in
Co-investorsKaleida CapitalDeep Future
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.